Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant

Am J Med. 2017 May;130(5):e195-e197. doi: 10.1016/j.amjmed.2016.11.029. Epub 2016 Dec 21.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Anticoagulants / adverse effects*
  • Antidotes / therapeutic use*
  • Blood Coagulation / drug effects*
  • Dabigatran / antagonists & inhibitors*
  • Hemorrhage / drug therapy
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Anticoagulants
  • Antidotes
  • idarucizumab
  • Dabigatran